FDA Clearance Tracker · P070008-S107
Corox OTW BP
Last checked: Nov 20, 2026Latest source record: Oct 4, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Oct 4, 2019
Approved
Time to decision
35 days
Received Aug 30, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P070008-S107
- Device name
- Corox OTW BP
- Applicant
- Biotronik, Inc.
- Applicant location
- Lake Oswego, OR
- Received
- Aug 30, 2019
- Decided
- Oct 4, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P070008
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for labeling updates to the clinical study summary for the post approval study.
Source documents
Other decisions for Biotronik, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- BIOMONITOR IV (471155)510(k)
K261074 · Decided May 1, 2026 · 30 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.